EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Lactylation in Cardiovascular Diseases: Current Progress and Perspectives

Zhi-Mo Wang, Qing-Wen Yu, Cong Wang, Shu-Hui Wang, Pei Wang, Li-Rong Zhang, Sheng-Na Han iD

Journal of the American Heart Association · 07.10.2025 · 14 (19)

DOI: 10.1161/jaha.125.043801 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 07.10.2025. Verfasst von Zhi-Mo Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences Zhengzhou University Zhengzhou China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Protein Processing, Post-Translational. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence suggests that epigenetic modifications, including lactylation—a recently identified posttranslational modification—may play a role in cardiovascular diseases (CVDs). Lactylation occurs in both histone and nonhistone proteins and has been implicated in processes, such as inflammation, lipid metabolism, and angiogenesis, which are relevant to CVD pathogenesis. However, the mechanistic links between lactylation and CVDs remain poorly understood, with most supporting evidence derived from preclinical studies. This review summarizes the current knowledge on lactylation, including its regulatory enzymes and potential functional roles in CVDs. While preliminary, these insights may inform future research directions for therapeutic strategies, early diagnostics, and disease prevention. Further validation in clinical studies is needed to establish the significance of lactylation in CVDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesProtein Processing, Post-TranslationalHumansAnimalsEpigenesis, GeneticHistones

Stichwörter der Autor:innen

epigenetic modificationhistonelactylation cardiovascular diseases

Substanzen

Histones

Autor:innen und Institutionen

  • Department of Pharmacology, School of Basic Medical Sciences Zhengzhou University Zhengzhou China.
  • Department of Ultrasound The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou China.

ORCID-Profile: Sheng-Na Han

Zitieren

APA

Wang, Z. M., Yu, Q. W., Wang, C., Wang, S. H., Wang, P., Zhang, L. R., & Han, S. N. (2025). Lactylation in Cardiovascular Diseases: Current Progress and Perspectives. Journal of the American Heart Association, 14(19). https://doi.org/10.1161/jaha.125.043801

Vancouver

Wang ZM, Yu QW, Wang C, Wang SH, Wang P, Zhang LR, et al. Lactylation in Cardiovascular Diseases: Current Progress and Perspectives. Journal of the American Heart Association. 2025;14(19). doi:10.1161/jaha.125.043801

BibTeX
@article{Wang2025,
  author = {Wang, Zhi-Mo and Yu, Qing-Wen and Wang, Cong and Wang, Shu-Hui and Wang, Pei and Zhang, Li-Rong and Han, Sheng-Na},
  title = {Lactylation in Cardiovascular Diseases: Current Progress and Perspectives},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {19},
  doi = {10.1161/jaha.125.043801}
}
Kostenlos starten →